Although these mutations occur in a small subset of patients, the significant role of TDP-43 as a causative factor in ALS has been highlighted by its identification as the main component of proteinaceous aggregates in post-mortem tissues of ALS patients [19–21]. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.